Search - tctmd.com

Displaying 1 - 20 of 209

Sort: Relevancy | Date

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 3: Forma Description, Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian, Josep Rodés-Cabau

November 01, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the Cardia LAA Occluder

Presenter: Krzysztof Bartus, Josep Rodés-Cabau

November 01, 2016

Presentation TCT 2016

Interatrial Shunts in HFrEF: Focus on V-Wave

Presenter: Josep Rodés-Cabau, Nir Uriel, William T. Abraham

November 01, 2016

Presentation TCT 2016

Interatrial Shunts in HFpEF: Focus on Corvia

Presenter: Josep Rodés-Cabau, Nir Uriel, Sanjiv Shah

November 01, 2016

Presentation TCT 2016

Interatrial Shunts: Theoretical Basis and Unanswered Questions

Presenter: Josep Rodés-Cabau, Nir Uriel, Daniel Burkhoff

November 01, 2016

Presentation TCT 2016

The Case for Transcatheter Therapy

Presenter: Michael A. Borger, Vinod H. Thourani, Josep Rodés-Cabau

November 01, 2016

Presentation TCT 2016

Percutaneous Coronary Intervention with the ANgiolite Drug-Eluting Stent: an Optical CoHerence TOmogRaphy Study. The ANCHOR Study

Presenter: Fernando Alfonso, Ran Kornowski, Josep Rodés-Cabau

November 01, 2016

Presentation TCT 2016

Tricuspid Repair with the Trialign System

Presenter: Eric Horlick, Josep Rodés-Cabau, Charles J. Davidson

October 31, 2016

Presentation TCT 2016

Transcatheter Valve Repair Solution - When, After the Mitral Valve, the Tricuspid Should Be Treated

Presenter: Eric Horlick, Josep Rodés-Cabau, Maurizio Taramasso

October 31, 2016

Presentation TCT 2016

Trialign for Functional TR: Early US Experience

Presenter: Eric Horlick, Josep Rodés-Cabau, Charles J. Davidson

October 31, 2016

Presentation TCT 2016

Editorial Perspective: Embolic Protection in TAVR Intervention

Presenter: Josep Rodés-Cabau

October 31, 2016

Presentation TCT 2016

Severe AS With a Small Aortic Annulus

Presenter: Howard C. Herrmann, Vinod H. Thourani, Josep Rodés-Cabau

October 31, 2016

Presentation TCT 2016

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Brian K. Whisenant

October 30, 2016

Presentation TCT 2016

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Debate #1: Should Low bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Yes As Long As Full Consent Is Provided, Let the Patient Decide!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, David Hildick-Smith

October 30, 2016

Presentation TCT 2016

Debate #1: Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? No Chronic Anticoagulation Should be Offered First

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Stefan C. Bertog

October 30, 2016

Presentation TCT 2016

Early Clinical Results With the Cardia LAA Occluder (and Future Studies)

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Josep Rodés-Cabau

October 30, 2016

Presentation TCT 2016

Foldax: Preclinical Results With a Novel Thin-leaflet Synthetic Valve

Presenter: Mark Reisman, Josep Rodés-Cabau, Steven J. Yakubov

October 30, 2016

Presentation TCT 2016

A Novel Bioprosthesis Designed for Optimization of Valve-in-Valve Procedures

Presenter: Mark Reisman, Josep Rodés-Cabau, Danny Dvir

October 30, 2016

Presentation TCT 2016

Total Embolic Protection in TAVR Procedures (Emboline)

Presenter: Mark Reisman, Josep Rodés-Cabau, Scott Russell

October 30, 2016

Advertisement

Transcatheter Tricuspid Valve Therapies 3: Forma Description, Results and a Case

Special Tips and Tricks for LAA Closure Using the Cardia LAA Occluder

Interatrial Shunts in HFrEF: Focus on V-Wave

Interatrial Shunts in HFpEF: Focus on Corvia

Interatrial Shunts: Theoretical Basis and Unanswered Questions

The Case for Transcatheter Therapy

Percutaneous Coronary Intervention with the ANgiolite Drug-Eluting Stent: an Optical CoHerence TOmogRaphy Study. The ANCHOR Study

Tricuspid Repair with the Trialign System

Transcatheter Valve Repair Solution - When, After the Mitral Valve, the Tricuspid Should Be Treated

Trialign for Functional TR: Early US Experience

Editorial Perspective: Embolic Protection in TAVR Intervention

Severe AS With a Small Aortic Annulus

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes!

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

Debate #1: Should Low bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Yes As Long As Full Consent Is Provided, Let the Patient Decide!

Debate #1: Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? No Chronic Anticoagulation Should be Offered First

Early Clinical Results With the Cardia LAA Occluder (and Future Studies)

Foldax: Preclinical Results With a Novel Thin-leaflet Synthetic Valve

A Novel Bioprosthesis Designed for Optimization of Valve-in-Valve Procedures

Total Embolic Protection in TAVR Procedures (Emboline)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content